Witte Alexander, Chatterjee Madhumita, Lang Florian, Gawaz Meinrad
Cell Physiol Biochem. 2017;41(4):1684-1696. doi: 10.1159/000471821. Epub 2017 Mar 29.
Platelets are a major source of chemokines. Here, we demonstrate for the first time that platelets express significant amounts of CXCL14 and disclose powerful effects of platelet-derived CXCL14 on monocyte and endothelial migration.
The expression of CXCL14 in platelets and in the supernatant of activated platelets was analysed by immunoblotting, ELISA, and flow cytometry. The effect of platelet-derived CXCL14 on monocyte migration was evaluated using a modified Boyden chamber. The effect of CXCL14 on monocyte phagocytosis was tested by using fluorochrome-labelled E.coli particles. The effect of platelet-derived CXCL14 on endothelial migration was explored by the use of an endothelial scratch assay.
Hitherto unrecognized expression of CXCL14 in human and murine platelets was uncovered by immunoblotting. Activation with platelet agonists such as adenosine-di-phosphate (ADP), collagen-related peptide (CRP), or thrombin-receptor activating peptide (TRAP), increased CXCL14 surface expression (flow cytometry) and release into the supernatant (immunoblotting, ELISA). Since CXCL14 is known to be chemotactic for CD14+ monocytes, we investigated the chemotactic potential of platelet-derived CXCL14 on human monocytes. Activated platelet supernatant induced monocyte migration, which was counteracted upon neutralization of platelet-derived CXCL14 as compared to IgG control. Blocking of the chemokine receptor CXCR4, but not CXCR7, reduced the number of migratory monocytes towards recombinant CXCL14, suggesting the involvement of CXCR4 in the CXCL14-directed monocyte chemotaxis. Recombinant CXCL14 enhanced the phagocytic uptake of E.coli particles by monocytes. In scratch assays with cultured endothelial cells (HUVECs), platelet-derived CXCL14 counteracted the pro-angiogenic effects of VEGF, supporting its previously recognized angiostatic potential.
Platelets are a relevant source of CXCL14. Platelet-derived CXCL14 at the site of vascular lesions might play an important role in vascular repair/regeneration.
血小板是趋化因子的主要来源。在此,我们首次证明血小板表达大量CXCL14,并揭示血小板源性CXCL14对单核细胞和内皮细胞迁移具有强大作用。
通过免疫印迹、酶联免疫吸附测定(ELISA)和流式细胞术分析CXCL14在血小板及活化血小板上清液中的表达。使用改良的博伊登小室评估血小板源性CXCL14对单核细胞迁移的影响。通过使用荧光标记的大肠杆菌颗粒检测CXCL14对单核细胞吞噬作用的影响。利用内皮细胞划痕试验探究血小板源性CXCL14对内皮细胞迁移的影响。
免疫印迹发现人及小鼠血小板中存在此前未被认识到的CXCL14表达。用二磷酸腺苷(ADP)、胶原相关肽(CRP)或凝血酶受体激活肽(TRAP)等血小板激动剂激活后,CXCL14的表面表达(流式细胞术)增加,且释放到上清液中(免疫印迹、ELISA)。由于已知CXCL14对CD14+单核细胞具有趋化作用,我们研究了血小板源性CXCL14对人单核细胞的趋化潜力。活化的血小板上清液诱导单核细胞迁移,与IgG对照相比,血小板源性CXCL14被中和后这种迁移作用受到抑制。趋化因子受体CXCR4而非CXCR7的阻断减少了迁移的单核细胞向重组CXCL14的数量,表明CXCR4参与了CXCL14介导的单核细胞趋化作用。重组CXCL14增强了单核细胞对大肠杆菌颗粒的吞噬摄取。在用培养的内皮细胞(人脐静脉内皮细胞,HUVECs)进行的划痕试验中,血小板源性CXCL14抵消了血管内皮生长因子(VEGF)的促血管生成作用,支持其先前被认可的血管生成抑制潜力。
血小板是CXCL14的相关来源。血管损伤部位的血小板源性CXCL14可能在血管修复/再生中起重要作用。